Notch2 activation is protective against anticancer effects of zerumbone in human breast cancer cells

Anuradha Sehrawat1, Kozue Sakao, Shivendra V Singh

  • 1Department of Pharmacology and Chemical Biology, University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine, 5117 Centre Avenue, Pittsburgh, PA, USA.

Insights

Zerumbone (ZER) activates Notch2, inhibiting its anticancer effects in breast cancer cells. This suggests Notch2 signaling plays a key role in ZER

Area of Science:

  • Oncology
  • Molecular Biology
  • Natural Products Chemistry

Background:

  • Zerumbone (ZER), a sesquiterpene from ginger, previously demonstrated anticancer properties by inhibiting breast cancer cell growth and inducing apoptosis.
  • The role of Notch receptors in ZER's anticancer mechanisms, specifically cell migration and apoptosis, remains to be fully elucidated.

Purpose of the Study:

  • To investigate the involvement of Notch receptors in the anticancer effects of zerumbone (ZER) on human breast cancer cells.
  • To determine how ZER influences Notch receptor cleavage, activation, and downstream signaling pathways.
  • To assess the impact of modulating Notch2 and Presenilin-1 on ZER's anti-migratory and pro-apoptotic activities.

Main Methods:

  • Western blotting to analyze protein expression levels of Notch receptors and related proteins.
  • Luciferase reporter assays to evaluate the transcriptional activity of Notch signaling.
  • RNA interference (siRNA/shRNA) to knockdown Notch2 and Presenilin-1 expression.
  • Boyden chamber assays and flow cytometry to quantify cell migration and apoptosis, respectively.

Main Results:

  • ZER exposure increased the cleavage of Notch2 while decreasing cleaved Notch1 and Notch4 in breast cancer cell lines (MDA-MB-231, MCF-7, SUM159).
  • Notch2 cleavage by ZER correlated with increased Presenilin-1 protein and Notch transcriptional activation.
  • Knockdown of Notch2 enhanced ZER's inhibition of cell migration and apoptosis induction.
  • Interference with Presenilin-1 attenuated ZER-mediated Notch2 cleavage and amplified ZER-induced apoptosis.

Conclusions:

  • ZER activates Notch2 signaling, which paradoxically dampens its own pro-apoptotic and anti-migratory effects in breast cancer cells.
  • Notch2 and Presenilin-1 are critical mediators of ZER's impact on breast cancer cell behavior.
  • Targeting the Notch2 pathway could potentially enhance the therapeutic efficacy of zerumbone in breast cancer treatment.

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
4.6K
Notch Signaling Pathway03:14

Notch Signaling Pathway

4.9K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
1.8K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.2K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

2.6K